Mislabeling of NSAID allergies poses risks for stroke patients

Credit: Unsplash+

A recent study from the University of Hong Kong’s LKS Faculty of Medicine (HKUMed) has shed light on the significant impact of mislabeled NSAID (Non-Steroidal Anti-Inflammatory Drug) allergies on stroke patients.

The findings, published in Stroke, highlight how such errors can hinder effective treatment, leading to poorer health outcomes. Alarmingly, the study found that 80% of stroke survivors labeled with NSAID allergies were incorrectly diagnosed.

The Role of NSAIDs in Stroke Treatment

Stroke is the second leading cause of death globally and the third most common cause of disability. Preventing a second stroke is critical, and aspirin, a widely used NSAID, is highly effective in reducing the risk of stroke recurrence by up to 60%.

It is also essential for managing other cardiovascular complications. However, patients with NSAID allergy labels are typically prohibited from taking aspirin, often forcing reliance on less effective alternatives that may increase health risks.

Mislabeling and Its Consequences

The study, led by Dr. Philip Li Hei and undergraduate medical student Cheryl Tsui Cheuk-wun during her Enrichment Year (EY) research attachment, analyzed the impact of NSAID allergy labels on 1,003 stroke patients. Comparing these patients to Hong Kong’s general population of over 7 million between 2008 and 2014, the research revealed:

  • Stroke patients were more likely to have NSAID allergy labels.
  • Those with these labels were significantly less likely to receive aspirin.
  • Patients with NSAID allergy labels faced a 7.44-times higher risk of death and a 6.1-times higher risk of major cardiovascular events.

These findings highlight a critical gap in patient care. Many patients were astonished to learn that their long-held allergy labels were incorrect, preventing them from receiving optimal treatment for years.

A Need for Better Allergy Testing

The study uncovered a widespread issue of inaccurate drug allergy labels in Hong Kong. Most patients with NSAID allergy labels had never undergone formal evaluation, even though proper testing revealed that 80% of these labels were incorrect.

Without such evaluations, patients are denied access to effective medications, putting them at unnecessary risk.

Dr. Gary Lau Kui-kai, Director of HKU Stroke, emphasized the importance of verifying drug allergies: “Patients with unverified allergy labels must undergo testing to determine if they can safely use NSAIDs again. This could save lives and improve outcomes for stroke survivors.”

Solutions and Future Directions

To address these challenges, Dr. Li and his team advocate for expanding drug allergy testing services in Hong Kong. They propose innovative solutions, such as empowering community pharmacists to conduct preliminary drug allergy evaluations in collaboration with HKUMed.

This approach could help bridge gaps in the healthcare system, allowing more patients to access safe and effective treatments.

Real-World Impact

For Cheryl Tsui, the study’s lead researcher, the findings are a testament to the value of integrating research into medical education. “It’s incredibly rewarding to know that my research can influence clinical practices and improve patient outcomes,” she said.

The study underscores the urgent need to improve drug allergy testing and management. By addressing mislabeled NSAID allergies, healthcare providers can ensure that stroke patients receive the most effective treatments, reducing their risk of recurrence, severe cardiovascular events, and death.

Conclusion

Mislabeling of NSAID allergies has far-reaching consequences, particularly for stroke survivors who rely on medications like aspirin for secondary prevention.

This study highlights the need for robust allergy evaluation systems and collaborative healthcare strategies to address these challenges. Correcting inaccurate labels can significantly improve treatment outcomes and quality of life for countless patients.

If you care about stroke, please read studies about how to eat to prevent stroke, and diets high in flavonoids could help reduce stroke risk.

For more information about health, please see recent studies about how Mediterranean diet could protect your brain health, and wild blueberries can benefit your heart and brain.

The research findings can be found in Stroke.

Copyright © 2025 Knowridge Science Report. All rights reserved.